Details

View this engaging discussion to explore the potential role of novel Factor XI/XIa inhibitors in stroke prevention, and to have your questions around anticoagulation for AF answered. 

Learning Objectives 

Following participation in this program, participants will be able to:

• Review the mechanisms underlying the potential superior safety of Factor XI/XIa inhibitors
• Discuss the results of preliminary clinical trials with these new agents
• Explore the role of these new agents in AF stroke prevention

Faculty

Milan Gupta, MD, FRCPC, FCCS, CPC(HC)

Shaun Goodman, MD, MSc, FRCPC, FACC, FAHA, FESC, FCCS

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.

This program was developed by CCRN and has received unrestricted educational grant funding.

Program slides:

A copy of the program slides is available for CCRN members with a resource library subscription. View pricing and download options on the Resources tab.